drugset / Trial / NCT07229807

Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A

NCT07229807

Phase 3 Active not recruiting 119 enrolled Guangdong Raynovent Biotech Co., Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is conducted in China. The aim of the trial is to investigate safety and efficacy of ZSP1273 granules

Timeline

Start
2025-11-22
Primary completion
2025-12-17
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Onradivir Small molecule Oral
Comparator Oseltamivir Small molecule Oral

Indications